Beta Drugs Limited

NSEI:BETA 株式レポート

時価総額:₹20.8b

Beta Drugs マネジメント

マネジメント 基準チェック /44

Beta Drugsの CEO はRahul Batraで、 Jan2021年に任命され、 の在任期間は 3.83年です。 の年間総報酬は₹ 12.10Mで、 100%給与と0%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.41%を直接所有しており、その価値は₹ 86.99M 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と7.3年です。

主要情報

Rahul Batra

最高経営責任者

₹12.1m

報酬総額

CEO給与比率100.0%
CEO在任期間3.8yrs
CEOの所有権0.4%
経営陣の平均在職期間3.8yrs
取締役会の平均在任期間7.3yrs

経営陣の近況

Chairman & MD Vijay Batra Just Bought A Handful Of Shares In Beta Drugs Limited (NSE:BETA)

Nov 20
Chairman & MD Vijay Batra Just Bought A Handful Of Shares In Beta Drugs Limited (NSE:BETA)

Recent updates

Why Investors Shouldn't Be Surprised By Beta Drugs Limited's (NSE:BETA) 30% Share Price Surge

Nov 08
Why Investors Shouldn't Be Surprised By Beta Drugs Limited's (NSE:BETA) 30% Share Price Surge

Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?

Aug 30
Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?

Investors Appear Satisfied With Beta Drugs Limited's (NSE:BETA) Prospects As Shares Rocket 27%

Aug 30
Investors Appear Satisfied With Beta Drugs Limited's (NSE:BETA) Prospects As Shares Rocket 27%

Earnings Tell The Story For Beta Drugs Limited (NSE:BETA) As Its Stock Soars 29%

Dec 23
Earnings Tell The Story For Beta Drugs Limited (NSE:BETA) As Its Stock Soars 29%

Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?

Dec 11
Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?

These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well

Jul 29
These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well

Here's Why We Think Beta Drugs (NSE:BETA) Is Well Worth Watching

Jun 17
Here's Why We Think Beta Drugs (NSE:BETA) Is Well Worth Watching

Here's Why I Think Beta Drugs (NSE:BETA) Might Deserve Your Attention Today

Feb 21
Here's Why I Think Beta Drugs (NSE:BETA) Might Deserve Your Attention Today

Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly

Dec 20
Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Beta Drugs (NSE:BETA) Is Interesting

Nov 21
With EPS Growth And More, Beta Drugs (NSE:BETA) Is Interesting

These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well

Sep 02
These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well

Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly

May 20
Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly

Is Beta Drugs (NSE:BETA) A Risky Investment?

Jan 29
Is Beta Drugs (NSE:BETA) A Risky Investment?

Is Beta Drugs Limited's (NSE:BETA) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Dec 25
Is Beta Drugs Limited's (NSE:BETA) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Chairman & MD Vijay Batra Just Bought A Handful Of Shares In Beta Drugs Limited (NSE:BETA)

Nov 20
Chairman & MD Vijay Batra Just Bought A Handful Of Shares In Beta Drugs Limited (NSE:BETA)

CEO報酬分析

Beta Drugs の収益と比較して、Rahul Batra の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

₹410m

Jun 30 2024n/an/a

₹387m

Mar 31 2024₹12m₹12m

₹364m

Dec 31 2023n/an/a

₹356m

Sep 30 2023n/an/a

₹348m

Jun 30 2023n/an/a

₹327m

Mar 31 2023₹12mn/a

₹307m

Dec 31 2022n/an/a

₹298m

Sep 30 2022n/an/a

₹289m

Jun 30 2022n/an/a

₹269m

Mar 31 2022₹8m₹8m

₹248m

Dec 31 2021n/an/a

₹216m

Sep 30 2021n/an/a

₹183m

Jun 30 2021n/an/a

₹150m

Mar 31 2021₹6m₹6m

₹117m

Dec 31 2020n/an/a

₹106m

Sep 30 2020n/an/a

₹95m

Jun 30 2020n/an/a

₹94m

Mar 31 2020₹5m₹5m

₹94m

Sep 30 2019n/an/a

₹97m

Jun 30 2019n/an/a

₹89m

Mar 31 2019₹1m₹1m

₹80m

報酬と市場: Rahulの 総報酬 ($USD 143.42K ) は、 Indian市場 ($USD 179.34K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Rahulの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Rahul Batra (41 yo)

3.8yrs

在職期間

₹12,100,000

報酬

Mr. Rahul Batra serves as the Chairman & Managing Director of Beta Drugs Limited since January 27, 2021. He had been Whole Time Director of Beta Drugs Limited since August 1, 2014 until January 27, 2021. H...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Rahul Batra
Chairman & MD3.8yrs₹12.10m0.41%
₹ 85.7m
Varun Batra
Joint MD & Whole Time Director3.8yrs₹12.10m0.35%
₹ 71.8m
Nipun Arora
Chief Financial Officer3.7yrs₹3.10mデータなし
Rajni Brar
Company Secretary & Compliance Officer7.3yrs₹911.55kデータなし
Ashutosh Shukla
VP of Sales & Marketing and Whole Time Director5.7yrs₹5.12mデータなし
Seema Chopra
Whole Time Directorno data₹1.19mデータなし
Sanjeev Chopra
Vice President of Technicalno dataデータなしデータなし

3.8yrs

平均在職期間

40.5yo

平均年齢

経験豊富な経営陣: BETAの経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Rahul Batra
Chairman & MD10.3yrs₹12.10m0.41%
₹ 85.7m
Varun Batra
Joint MD & Whole Time Director10.3yrs₹12.10m0.35%
₹ 71.8m
Ashutosh Shukla
VP of Sales & Marketing and Whole Time Director2.8yrs₹5.12mデータなし
Seema Chopra
Whole Time Director5.3yrs₹1.19mデータなし
Manmohan Khanna
Independent Director7.3yrsデータなしデータなし
Rohit Parti
Independent Director7.3yrsデータなしデータなし

7.3yrs

平均在職期間

48yo

平均年齢

経験豊富なボード: BETAの 取締役会経験豊富 であると考えられます ( 7.3年の平均在任期間)。